Strategies for the rational use of antimicrobials

Clinical Infectious Diseases

Volumn 24, Issue 1 SUPPL., 1997, Pages

  Couper, M R ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; BENZATHINE; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; METRONIDAZOLE; NALIDIXIC ACID; NITROFURANTOIN; PENICILLIN DERIVATIVE; PENICILLIN G; PENICILLIN V; PROCAINE PENICILLIN; SPECTINOMYCIN; SULFADIMIDINE; TRIMETHOPRIM; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; DRUG USE; HUMAN; NONHUMAN; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG INDUSTRY; DRUG RESISTANCE, MICROBIAL; DRUG UTILIZATION; HUMANS;

EID: 0031021978     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/24.supplement_1.s154     Document Type: Article

References (18)

1. The selection of essential drugs. Report of the WHO Expert Committee. Geneva: World Health Organization, 1977 (WHO technical report series, no. 615).
2. WHO model list: revised in December 1995. WHO Drug Information 1995:9(4).
3. Antimicrobial resistance: implications for drug registration. In: Report of the International Conference of Drug Regulatory Authorities. Amsterdam: Ministry of Welfare, Health and Cultural Affairs, 1994.
4. The use of essential drugs. Model list of essential drugs (eighth list). Sixth report of the WHO Expert Committee. Geneva: World Health Organization, 1995 (WHO technical report series, no. 850).
5. WHO model prescribing information: drugs used in parasitic diseases. Geneva: World Health Organization, 1990.
6. WHO model prescribing information: drugs used in mycobacterial diseases. Geneva: World Health Organization, 1991.
7. WHO model prescribing information: drugs used in sexually transmitted diseases and HIV. Geneva: World Health Organization, 1995.
8. The management and prevention of diarrhoea: practical guidelines. 3rd ed. Geneva: World Health Organization, 1993.
9. Acute respiratory infections in children: case management in small hospitals in developing countries. Geneva: World Health Organization, 1990; reprinted 1992 (unpublished document WHO/ARI/90.5, available from the Division of Diarrhoeal and Acute Respiratory Disease Control, World Health Organization, 1211 Geneva 27, Switzerland).
10. Treatment of tuberculosis: guidelines for national programmes. Geneva: World Health Organization, 1993.
11. Management of severe and complicated malaria: a practical handbook. Geneva: World Health Organization, 1991.
12. Guidelines for antimicrobial susceptibility testing for intermediate laboratories. In: The use of essential drugs. Sixth report of the WHO Expert Committee. Geneva: World Health Organization, 1995 (WHO technical report series, no. 850; annex 2).
13. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirty-fourth report. Geneva: World Health Organization, 1997 (WHO technical report series, no, 863).
14. Guiding principles for small national drug regulatory auhorities. In: The use of essential drugs. Model list of essential drugs (seventh list). Fifth report of the WHO Expert Committee. Geneva: World Health Organization, 1992 (WHO technical report series, no. 825; annex 1).
15. Good manufacturing practices for pharmaceutical products. In: WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirty-second report. Geneva: World Health Organization, 1992 (WHO technical report series, no. 823; annex 1).
16. Proposed guidelines for implementation of the WHO Certification Scheme on the Quality of Pharmaceutical Products Moving in International Commerce. In: WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirty-second report. Geneva: World Health Organization, 1992 (WHO technical report series, no. 823; annex 3).
17. Provision and dissemination of drug information. In: The use of essential drugs. Sixth report of the WHO Expert Committee. Geneva: World Health Organization, 1995 (WHO technical report series, no. 850; annex 1).
18. Ethical criteria for medicinal drug promotion. Geneva: World Health Organization, 1988.